CYCCThe stock held up well in a weak market environment on Friday. Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) broke resistance, but it was during the first 15 minutes of the day, which is not a good time to trade. The stock ended the day at the previous day's closing price of 7.11, and registered an intraday range of 6.97 and 7.75. A close abv 7.60 is important to continue the rebound toward 8.95. Oppenheimer analyst Kevin DeGeeter initiated coverage of Cyclacel Pharmaceuticals yesterday with an Outperform rating and 17 price target. This is for patient traders. If you're not patient, go to the casino.
